Navigation Links
New Hope for Liver Diseases
Date:5/23/2008

Scientists generate liver cells from embryonic stem cells, find clues to predict response to therapy

FRIDAY, May 23 (HealthDay News) -- Human liver cells have been generated from embryonic stem cells using a new model, hopefully opening the door to help scientists screen for harmful side effects of new drugs before they are used in patients.

That was one of several reports on advances against liver diseases that were presented this week at Digestive Disease Week 2008 in San Diego.

Other presentations involved ways to predict which patients with hepatitis C might benefit from long-term antibiotic therapy and information about how monitoring the body's viral load in hepatitis B patients may help predict liver cancer.

Scientists from the University of Edinburgh, Scotland, reported they had efficiently generated human liver cells from embryonic stem cells without the problems that have plagued scientists in the past. The new model is unique, said Dr. David Hay, a senior fellow at the university's MRC Centre for Regenerative Medicine, who spoke at a press conference Tuesday.

His team developed a model that allows them to focus on key enzymes which are crucial in drug metabolism. Other clinical applications, he said, include the fact that the liver cells generated in vitro could be used in bioartificial devices, helping maintain normal function when the liver fails.

Down the road, said another investigator, Dr. Philip Newsome, the hope is that the cells could be used in liver transplantation.

The advance was praised by the press conference moderator, Dr. John M. Vierling, chief of hepatology at Baylor College of Medicine, in Houston.

The team produced "highly differentiated cells that maintain function," Vierling said, a feat that has thus far proved elusive to others working on the effort. "It is an extraordinarily rich advance to be exploited in many ways," he added.


'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Sea Buckthorn Leaves May Hold Benefit for the Liver
2. Arctic explorer delivers unique snow-depth data for CryoSat
3. Miracle leaves that may help protect against liver damage
4. The Childrens Hospital of Philadelphia Opens the Worlds First Delivery Unit for Mothers Diagnosed with Birth Defects in Fetus
5. What roles does TSP-1 play in liver fibrogenesis?
6. Is extra-corporal liver support with prometheus safe in patients with end-stage liver disease?
7. Medco, Healthways Launch Center for Health Action to Deliver Optimal Health(TM)
8. Risk threshold of daily alcohol intake and drinking duration in liver injury?
9. Study concludes no racial disparities in long-term outcomes in recipients of liver transplants
10. AmeriCares Delivers Life-Saving Aid to Myanmar
11. Supreme Master Ching Hai International Association Delivering US$160,000 in Aid to Earthquake Survivors in China
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Hope for Liver Diseases
New Hope for Liver Diseases
Breaking Medicine Technology:AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 3Pharmacy Technician Employment Increasing Up to 32% By 2016 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6HMS Holdings Corp to Present at William Blair 29th Annual Growth Stock Conference 48209 1Toms of Maine Invites Public Participation in 50 States for Good Program 48207 1Toms of Maine Invites Public Participation in 50 States for Good Program 48207 2University of Michigan Installs Neuro Kinetics I Portal 28R 29 NOTC System 12527 1University of Michigan Installs Neuro Kinetics I Portal 28R 29 NOTC System 12527 2University of Michigan Installs Neuro Kinetics I Portal 28R 29 NOTC System 12527 3